Joanne Buzaglo
Overview
Explore the profile of Joanne Buzaglo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bantum E, Elhadad N, Owen J, Zhang S, Golant M, Buzaglo J, et al.
J Technol Behav Sci
. 2021 Mar;
5(4):416.
PMID: 33778157
[This corrects the article PMC7467127.].
2.
Franklin E, Nichols H, House L, Buzaglo J, Thiboldeaux K
J Patient Exp
. 2021 Jan;
7(6):1115-1121.
PMID: 33457553
Sharing data is critical to advancing science, improving health, and creating advances in the delivery of health care services. The value of sharing data for cancer research purposes is well...
3.
Bantum E, Elhadad N, Owen J, Zhang S, Golant M, Buzaglo J, et al.
J Technol Behav Sci
. 2020 Sep;
2(1):21-27.
PMID: 32885036
Expression of emotion has been linked to numerous critical and beneficial aspects of human functioning. Accurately capturing emotional expression in text grows in relevance as people continue to spend more...
4.
Greer J, Jacobs J, Pensak N, Nisotel L, Fishbein J, MacDonald J, et al.
J Natl Compr Canc Netw
. 2020 Feb;
18(2):133-141.
PMID: 32023526
Background: Patients with cancer are increasingly prescribed oral therapies, bearing greater responsibility for self-management of treatment adherence and adverse events. We conducted a randomized trial to test the use of...
5.
Paladino A, Anderson J, Krukowski R, Waters T, Kocak M, Graff C, et al.
BMC Health Serv Res
. 2019 Dec;
19(1):977.
PMID: 31856812
Background: Long-term use of adjuvant endocrine therapy (AET) among women with early-stage, hormone receptor-positive breast cancer significantly reduces the risk of hospitalizations, cancer recurrence, and mortality. AET is associated with...
6.
Jacobs J, Ream M, Pensak N, Nisotel L, Fishbein J, MacDonald J, et al.
J Natl Compr Canc Netw
. 2019 Mar;
17(3):221-228.
PMID: 30865917
Background: Oral therapies are increasingly common in oncology care. However, data are lacking regarding the physical and psychologic symptoms patients experience, or how these factors relate to medication adherence and...
7.
Paladino A, Anderson J, Graff J, Krukowski R, Blue R, Jones T, et al.
Psychooncology
. 2019 Jan;
28(3):570-576.
PMID: 30636189
Objective: Social support is a critical component of breast cancer care and is associated with clinical and quality of life outcomes. Significant health disparities exist between Black and White women...
8.
Saxton C, Buzaglo J, Rochman S, Zaleta A
Am J Manag Care
. 2017 Mar;
23(2 Spec No.):SP78-SP80.
PMID: 28298131
No abstract available.
9.
Meropol N, Wong Y, Albrecht T, Manne S, Miller S, Flamm A, et al.
J Clin Oncol
. 2015 Dec;
34(5):469-78.
PMID: 26700123
Purpose: Lack of knowledge and negative attitudes have been identified as barriers to participation in clinical trials by patients with cancer. We developed Preparatory Education About Clinical Trials (PRE-ACT), a...
10.
Wong Y, Schluchter M, Albrecht T, Benson 3rd A, Buzaglo J, Collins M, et al.
J Clin Oncol
. 2015 Dec;
34(5):479-87.
PMID: 26700120
Purpose: The decision to enroll in a clinical trial is complex given the uncertain risks and benefits of new approaches. Many patients also have financial concerns. We sought to characterize...